BONH
BIIB icon

Bank of New Hampshire’s Biogen BIIB Stock Holding History

Bank of New Hampshire’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$4.52K Hold
20
– – ﹤0.01% 495
2026
Q2 		$4.32K Hold
20
– – ﹤0.01% 497
2026
Q1 		$3.67K Buy
+20
New +$3.69K ﹤0.01% 504

Other funds holding BIIB

AIM
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
TF
Tompkins Financial Ithaca, New York $1.42B AUM 19.14% 1-Year Est. Return
BCM
Boltwood Capital Management Walnut Creek, California $443M AUM 17.72% 1-Year Est. Return
EFG
Everhart Financial Group Dublin, Ohio $1.62B AUM 25.73% 1-Year Est. Return
CI
CX Institutional Auburn, Indiana $3.69B AUM 15.82% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
IRC
Investors Research Corp Atlanta, Georgia $569M AUM 15.41% 1-Year Est. Return

Bank of New Hampshire's BIIB Position: Q3 2026 in Review

Bank of New Hampshire held its Biogen (BIIB) position steady in Q3 2026 at 20 shares worth $4.52K. The position accounts for ﹤0.01% of the portfolio, ranked #495.

Bank of New Hampshire first reported a position in BIIB in Q1 2026 and has held it in 3 quarters since. 31 funds tracked by Wall St. Rank hold BIIB as of Q3 2026.

  • Bank of New Hampshire held 20 shares of Biogen worth $4.52K as of Q3 2026.
  • Bank of New Hampshire left its Biogen share count unchanged in Q3 2026.
  • Biogen made up ﹤0.01% of Bank of New Hampshire's portfolio in Q3 2026, its #495 holding.
  • Bank of New Hampshire first reported a position in Biogen in Q1 2026 and has held it in 3 quarters since.
  • 31 funds tracked by Wall St. Rank held Biogen as of Q3 2026.

Based on Bank of New Hampshire's 13F filing for Q3 2026, filed 6 Oct 2026.